According to a new report, published by KBV research, The Global Livestock Parasiticides Market size is expected to reach $3.9 Billion by 2029, rising at a market growth of 5.9% CAGR during the forecast period.
The Endoparasiticides market would showcase a CAGR of 6.3% during (2023 - 2029). Internal parasites like tapeworms, roundworms, and flukes can be managed with endoparasiticides. As internal parasites, including roundworms, tapeworms, and flukes, are becoming more common, there is a greater demand for endoparasiticides, which in turn is driving the expansion of the endoparasiticides market.
The Veterinary Clinics & Hospitals market is leading the Global Livestock Parasiticides Market by End User in 2022; thereby, achieving a market value of $2.7 billion by 2029. This is because these clinics offer more livestock, pushing the demand for veterinary clinics and hospitals worldwide. The rising livestock population drives the global demand for veterinary hospitals and clinics. In addition, the Covid-19 pandemic's lockdown destruction raised awareness of animal health issues.
The Poultry market is estimated to grow at a CAGR of 6.1% during (2023 - 2029). Developing countries like India, China, and Africa consume more meat. More cattle are being fed and raised as livestock worldwide due to the rising demand for food products made from animals, like meat. The growing market for animal goods in developing nations is mostly to blame for the increased demand for meat.
The North America market dominated the Global Livestock Parasiticides Market by Region in 2022; thereby, achieving a market value of $1.4 billion by 2029. The Asia Pacific market is poised to grow at a CAGR of 6.9% during (2023 - 2029). Additionally, The Europe market would experience a CAGR of 5.2% during (2023 - 2029).
Full Report: https://www.kbvresearch.com/livestock-parasiticides-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country-wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Boehringer Ingelheim International GmbH, Elanco Animal Health, Inc., Virbac, Zoetis, Inc., PetIQ, Inc., Merck & Co., Inc., Vetoquinol SA, Norbrook Laboratories Limited, Bimeda, Inc., and Ceva Santé Animale
By Type
By End User
By Livestock
By Geography
Companies Profiled
Unique Offerings 
